Abiopharma

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024885 <b>Size:</b> 833 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001214659-26-010872 <b>Size:</b> 371 KB

New Form S-8 - Digital Currency X Technology Inc. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001493152-26-040107 <b>Size:</b> 464 KB

Mandatory Cash Dividend/ Distribution:

Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024884 <b>Size:</b> 536 KB

VCTR Stock Alert: Halper Sadeh LLC is Investigating Whether Victory Capital Holdings, Inc. is Obtaining a Fair Price for its Shareholders

(10% Negative) ASCENT INDUSTRIES CO. (ACNT) Announces Business Combination

Clinical trial NCT02159495 updates: 1. completion date: 2026-08-06 → 2027-07-14 2. primary completion date: 2026-08-06 → 2027-07-14

Clinical trial NCT04631601: enrollment: 65 → 55 participants.

Clinical trial NCT07341191: start date: 2026-08-31 → 2026-08-24.

Clinical trial NCT07663266 updates: 1. status: RECRUITING → COMPLETED 2. start date: 2026-05-25 → 2026-05-15 3. completion date: 2026-07-01 → 2026-07-28 4. primary completion date: 2026-07-01 → 2026-07-28 5. enrollment: 14 → 10 participants 6. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04518228: status: COMPLETED → TERMINATED.

Clinical trial NCT04025879: completion date: 2027-07-30 → 2027-07-31.

Clinical trial NCT07654283: start date: 2026-08-04 → 2026-08-27.